Browse by category

Gene therapy converts omega-6 to omega-3 fatty acids to combat effects of childhood obesity

Using gene therapy, Shriners Children's St. Louis researchers including Director of Research, Dr Farshid Guilak and Senior Scientist Dr...

Cutting-edge nanoparticle therapy targets fat absorption to combat obesity

A cutting-edge nanoparticle system, engineered to deliver therapeutic molecules directly to the digestive tract, has shown significant...

FDA grants Breakthrough Therapy designation for Zealand Pharma’s survodutide

The FDA has granted Breakthrough Therapy designation to Zealand Pharma’s survodutide (BI 456906), a dual glucagon/GLP-1 receptor agonist...

Lilly and UK government announce £279 million collaboration to tackle population health challenges including obesity

Eli Lilly and Company has announced a strategic collaboration with the UK’s Department of Health and Social Care (DHSC), Department for...

ReCET procedure plus semaglutide may eliminate insulin dependency in T2D

A promising new treatment strategy for type 2 diabetes (T2D) that combines a novel procedure known as ReCET (Re-Cellularization via...

AP39 compound delivers hydrogen sulfide directly to mitochondria cells induces weight loss

A study led by Jagiellonian University Medical College in Poland and the University of Exeter, UK, mice who were fed a high-fat diet and...

Metabolic syndrome factors associated with increased bowel cancer risk

Metabolic disorders such as obesity, high blood pressure and non-alcoholic fatty liver diseases have been directly linked to an increased...

BMS may lower risk of pancreatic cancer in people with obesity

Bariatric and metabolic surgery may lower the risk of developing pancreatic cancer in people with obesity especially in those who also...

Journal Watch 9/10/2024

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

FDA grants IND application for Antag Therapeutics’ AT-7687 molecule for obesity

The FDA has accepted Antag Therapeutics’ Investigational New Drug (IND) application for its lead molecule, AT-7687, for the treatment of...

Survey finds 50% of post-bariatric surgery patients feel less stress during the holidays

1 hour ago

Journal Watch 18/12/2024

4 hours ago

True You Weight Loss to initiate two clinical trials assessing gastric fundal mucosal ablation

5 hours ago

Weekly Digest